Affiance Financial’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.42M | Buy |
5,602
+1,524
| +37% | +$355K | 0.2% | 48 |
|
|
2026
Q1 | $997K | Buy |
4,078
+35
| +0.9% | +$8.15K | 0.16% | 54 |
|
|
2025
Q4 | $837K | Sell |
4,043
-211
| -5% | -$41.7K | 0.13% | 58 |
|
|
2025
Q3 | $789K | Sell |
4,254
-172
| -4% | -$29.5K | 0.14% | 60 |
|
|
2025
Q2 | $676K | Sell |
4,426
-562
| -11% | -$86.4K | 0.14% | 60 |
|
|
2025
Q1 | $827K | Sell |
4,988
-161
| -3% | -$25.2K | 0.19% | 53 |
|
|
2024
Q4 | $745K | Sell |
5,149
-333
| -6% | -$51.6K | 0.18% | 60 |
|
|
2024
Q3 | $889K | Sell |
5,482
-66
| -1% | -$10.5K | 0.22% | 53 |
|
|
2024
Q2 | $811K | Sell |
5,548
-37
| -0.7% | -$5.5K | 0.21% | 54 |
|
|
2024
Q1 | $884K | Sell |
5,585
-7
| -0.1% | -$1.11K | 0.24% | 52 |
|
|
2023
Q4 | $877K | Sell |
5,592
-149
| -3% | -$22.8K | 0.26% | 56 |
|
|
2023
Q3 | $894K | Sell |
5,741
-420
| -7% | -$69.3K | 0.45% | 51 |
|
|
2023
Q2 | $1.02M | Sell |
6,161
-10
| -0.2% | -$1.61K | 0.5% | 48 |
|
|
2023
Q1 | $957K | Buy |
6,171
+2
| +0% | +$323 | 0.51% | 46 |
|
|
2022
Q4 | $1.09M | Sell |
6,169
-557
| -8% | -$96.2K | 0.44% | 41 |
|
|
2022
Q3 | $1.1M | Sell |
6,726
-947
| -12% | -$160K | 0.62% | 28 |
|
|
2022
Q2 | $1.36M | Sell |
7,673
-511
| -6% | -$91K | 0.73% | 23 |
|
|
2022
Q1 | $1.45M | Sell |
8,184
-2,022
| -20% | -$344K | 0.7% | 26 |
|
|
2021
Q4 | $1.75M | Sell |
10,206
-119
| -1% | -$19.5K | 0.73% | 32 |
|
|
2021
Q3 | $1.67M | Hold |
10,325
| – | – | 0.73% | 30 |
|
|
2021
Q2 | $1.7M | Sell |
10,325
-285
| -3% | -$47.2K | 0.72% | 29 |
|
|
2021
Q1 | $1.74M | Buy |
10,610
+15
| +0.1% | +$2.43K | 0.78% | 26 |
|
|
2020
Q4 | $1.67M | Buy |
10,595
+176
| +2% | +$26K | 0.87% | 23 |
|
|
2020
Q3 | $1.55M | Buy |
10,419
+100
| +1% | +$14.8K | 0.9% | 24 |
|
|
2020
Q2 | $1.45M | Buy |
10,319
+143
| +1% | +$20.8K | 0.79% | 25 |
|
|
2020
Q1 | $1.33M | Hold |
10,176
| – | – | 0.92% | 21 |
|
|
2019
Q4 | $1.48M | Hold |
10,176
| – | – | 0.82% | 24 |
|
|
2019
Q3 | $1.32M | Sell |
10,176
-547
| -5% | -$72.1K | 0.8% | 25 |
|
|
2019
Q2 | $1.49M | Sell |
10,723
-1,353
| -11% | -$187K | 0.91% | 23 |
|
|
2019
Q1 | $1.69M | Sell |
12,076
-84
| -0.7% | -$11.3K | 1.06% | 21 |
|
|
2018
Q4 | $1.57M | Sell |
12,160
-71
| -0.6% | -$9.9K | 1.04% | 21 |
|
|
2018
Q3 | $1.69M | Buy |
12,231
+954
| +8% | +$127K | 1.11% | 16 |
|
|
2018
Q2 | $1.37M | Buy |
11,277
+2,730
| +32% | +$341K | 1.05% | 19 |
|
|
2018
Q1 | $1.09M | Sell |
8,547
-1,823
| -18% | -$246K | 0.97% | 18 |
|
|
2017
Q4 | $1.45M | Sell |
10,370
-424
| -4% | -$59.1K | 1.07% | 18 |
|
|
2017
Q3 | $1.4M | Buy |
10,794
+51
| +0.5% | +$6.76K | 1.13% | 18 |
|
|
2017
Q2 | $1.42M | Sell |
10,743
-138
| -1% | -$17.6K | 1.13% | 17 |
|
|
2017
Q1 | $1.35M | Buy |
10,881
+9
| +0.1% | +$1.07K | 1.05% | 19 |
|
|
2016
Q4 | $1.25M | Buy |
10,872
+11
| +0.1% | +$1.27K | 1% | 19 |
|
|
2016
Q3 | $1.28M | Buy |
10,861
+218
| +2% | +$26.4K | 1.04% | 17 |
|
|
2016
Q2 | $1.29M | Buy |
10,643
+161
| +2% | +$18.3K | 1.09% | 19 |
|
|
2016
Q1 | $1.13M | Hold |
10,482
| – | – | 1.09% | 21 |
|
|
2015
Q4 | $1.08M | Sell |
10,482
-357
| -3% | -$35.9K | 1.11% | 19 |
|
|
2015
Q3 | $1.01M | Buy |
10,839
+121
| +1% | +$11.7K | 1.27% | 19 |
|
|
2015
Q2 | $1.04M | Hold |
10,718
| – | – | 1.33% | 16 |
|
|
2015
Q1 | $1.08M | Buy |
10,718
+759
| +8% | +$77.2K | 1.64% | 12 |
|
|
2014
Q4 | $1.04M | Buy |
+9,959
| New | +$1.05M | 1.83% | 12 |
|
Other funds holding JNJ
AACR
Affiance Financial's JNJ Position: Q2 2026 in Review
Affiance Financial increased its Johnson & Johnson (JNJ) stake by 37% in Q2 2026, buying an estimated $355K and bringing the position to 5,602 shares worth $1.42M. The position accounts for 0.2% of the portfolio, ranked #48.
Affiance Financial first reported a position in JNJ in Q4 2014 and has held it in 47 quarters since. The position peaked at $1.75M in Q4 2021. 2,339 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Affiance Financial held 5,602 shares of Johnson & Johnson worth $1.42M as of Q2 2026.
- Affiance Financial bought 1,524 Johnson & Johnson shares in Q2 2026, an estimated $355K.
- Johnson & Johnson made up 0.2% of Affiance Financial's portfolio in Q2 2026, its #48 holding.
- Affiance Financial first reported a position in Johnson & Johnson in Q4 2014 and has held it in 47 quarters since.
- Affiance Financial's Johnson & Johnson position peaked at $1.75M in Q4 2021.
- 2,339 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Affiance Financial's 13F filing for Q2 2026, filed 9 Jul 2026.